Align Technology (NASDAQ:ALGN) been upgraded to outperform from market perform by Leerink Partners. Calling Align ...

Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Align Technology (NasdaqGS:ALGN) from ...

CureVac BV (CVAC) stock saw a modest uptick, ending the day at $4.44 which represents a slight increase of $0.82 or 22.65% from the prior close of $3.62. The stock opened at $4.14 and touched a low of ...

Leerink upgraded Quest Diagnostics (DGX) to Outperform from Market Perform with a price target of $174, up from $169. The firm notes its view ...

Align Technology upgraded by Leerink Partners with a $280 price target, citing growth potential, stock buyback plans, and global market expansion.

Faisal Khurshid, an analyst from Leerink Partners, maintained the Buy rating on Geron (GERN – Research Report). The associated price target ...

Align Technology (NASDAQ:ALGN – Get Free Report) was upgraded by investment analysts at Leerink Partners from a “market perform” rating to an “outperform” rating in a research note issued to investors ...

Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public ...

Leerink keeps an Outperform rating and a $60 price target on Kymera Therapeutics (KYMR) while noting that the firm sees a ...

Quest Diagnostics (NYSE:DGX – Get Free Report) was upgraded by Leerink Partners from a “market perform” rating to an ...